Production Method 1

149-91-7

950910-12-0

3934-84-7

530-57-4

1916-08-1

950910-16-4

950910-14-2

4319-02-2

Reaction Conditions

1.1 Reagents: Glucose ,  Sodium chloride ,  Dipotassium phosphate Solvents: Dimethylformamide ,  Water ;  6 d, pH 7.0, rt
1.2 Reagents: Hydrochloric acid Solvents: Water ;  acidified

Reference

Biotransformation of gallic acid by Beauveria sulfurescens ATCC 7159

Hsu, Feng-Lin; Yang, Li-Ming; Chang, Shwu-Fen; Wang, Li-Hsuan; Hsu, Chung-Yi; et al, Applied Microbiology and Biotechnology, 2007, 74(3), 659-666

3-Hydroxy-5-methoxy-4-[(4-O-methyl-β-D-glucopyranosyl)oxy]benzoic acid Raw materials

• Gallic acid

3-Hydroxy-5-methoxy-4-[(4-O-methyl-β-D-glucopyranosyl)oxy]benzoic acid Preparation Products

• 3-O-Methylgallic acid (3934-84-7)
• Syringic acid (530-57-4)
• 3-Hydroxy-5-methoxy-4-[(4-O-methyl-β-D-glucopyranosyl)oxy]benzoic acid (950910-12-0)
• 5-Hydroxyveratric acid (1916-08-1)
• 4''-methyloxy-Genistin (950910-16-4)
• β-D-Glucopyranose, 4-O-methyl-, 1-(3-hydroxy-4,5-dimethoxybenzoate) (950910-14-2)
• 3,5-Dihydroxy-4-methoxybenzoic Acid (4319-02-2)

• 1. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 2. Acetyl protected thiol methacrylic polymers as effective ligands to keep quantum dots in luminescent standby mode?
  Marta Liras,Isabel Quijada-Garrido,Marta Palacios-Cuesta,Sonia Mu?oz-Durieux,Olga García Polym. Chem., 2014,5, 433-442
• 3. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 4. An ion-gating multinanochannel system based on a copper-responsive self-cleaving DNAzyme?
  Yang Chen,Di Zhou,Zheyi Meng,Jin Zhai Chem. Commun., 2016,52, 10020-10023
• 5. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)